<html>
<head>PUBMED IDs for CD100</head>
<body bgcolor='#C5F0F2'><h1>CD100</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8876214/'>Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.</a> October 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9295286/'>The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity.</a> September 20  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9405678/'>Identification of semaphorin E as a non-MDR drug resistance gene of human cancers.</a> February 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9490301/'>Cloning and tissue expression of cDNAs from chromosome 5q21-22 which is frequently deleted in advanced lung cancer.</a> March 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9849618/'>CD100 is a leukocyte semaphorin.</a> December 16  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10520995/'>Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.</a> October 16  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10648410/'>Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage.</a> January 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254688/'>Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12533544/'>Functional regulation of semaphorin receptors by proprotein convertases.</a> January 21  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12882840/'>Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.</a> July 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14711056/'>Roles of the semaphorin family in immune regulation.</a> January 9  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14711054/'>B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders.</a> January 9  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16621959/'>In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.</a> April 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17244710/'>Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury.</a> January 25  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/21244334/'>Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients.</a> October 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21244330/'>CTLs' repertoire shaping in the thymus: a Monte Carlo simulation.</a> August 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22273152/'>Effects and mechanism of turmeric vasorelaxation of the thoracic aorta in hypercholesterolemic rats.</a> May 9  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22606231/'>Placental expression of CD100, CD72 and CD45 is dysregulated in human miscarriage.</a> October 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23741311/'>Increased levels of plasma soluble Sema4D in patients with heart failure.</a> February 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25239131/'>CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.</a> September 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26275342/'>CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis.</a> December 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26378166/'>CD8low CD100- T Cells Identify a Novel CD8 T Cell Subset Associated with Viral Control during Human Hantaan Virus Infection.</a> March 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26732941/'>The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases.</a> June 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28222623/'>Interferon-α-induced CD100 on naïve CD8(+) T cells enhances antiviral responses to hepatitis C infection through CD72 signal transduction.</a> May 16  2017<br></body></html>
